glp-1 liver disease Why are agonists being used to treat patients with nonalcoholic fatty disease? 8 Benefits of GLP‑1's Beyond

Chinese consumers increasingly view yerba mate as a functional alternative to green tea and energy drinks

June 2022, 1-day hybrid conference, Innsbruck, Austria

As a result, it may provide benefits for individuals with brain disorders and memory loss

A 32-year-old athlete with insulin resistance began semaglutide for weight loss

Weak signals watched: Insurers refused in spring 2026 to commit to a permanent version of GLP-1 weight-loss coverage, citing cost, and the Bridge's extension to 18 months was a reaction to insufficient insurer opt-in rather than a planned expansion

In vitro characterization of uptake mechanism of L-[methyl- 3H]-methionine in hepatocellular carcinoma